Ngā hua rapu - Geier, Jamie

Serious infections among a large cohort of subjects with systemically treated psoriasis mā Dobry, Allison S., Quesenberry, Charles P., Ray, G. Thomas, Geier, Jamie L., Asgari, Maryam M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Use of a risk characterisation approach to contextualise the safety profile of new rheumatoid arthritis treatments: a case study using tofacitinib mā Curtis, Jeffrey R., Zhang, Richard, Krishnaswami, Sriram, Anisfeld, Andrew, Chen, Yan, Strengholt, Sander, Chen, Connie, Geier, Jamie

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Mercury derived from dental amalgams and neuropsychologic function. mā Factor-Litvak, Pam, Hasselgren, Gunnar, Jacobs, Diane, Begg, Melissa, Kline, Jennie, Geier, Jamie, Mervish, Nancy, Schoenholtz, Sonia, Graziano, Joseph

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme mā Curtis, Jeffrey R, Lee, Eun Bong, Kaplan, Irina V, Kwok, Kenneth, Geier, Jamie, Benda, Birgitta, Soma, Koshika, Wang, Lisy, Riese, Richard

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry mā Pappas, Dimitrios A., Gerber, Robert A., Litman, Heather J., Gruben, David, Geier, Jamie, Hua, Winnie D., Chen, Connie, Li, Youfu, Kremer, Joel M., Andrews, John S., Bourret, Jeffrey A.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis mā Clowse, Megan E. B., Feldman, Steven R., Isaacs, John D., Kimball, Alexandra B., Strand, Vibeke, Warren, Richard B., Xibillé, Daniel, Chen, Yan, Frazier, Donald, Geier, Jamie, Proulx, James, Marren, Amy

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials mā Cohen, Stanley B, Tanaka, Yoshiya, Mariette, Xavier, Curtis, Jeffrey R, Lee, Eun Bong, Nash, Peter, Winthrop, Kevin L, Charles-Schoeman, Christina, Thirunavukkarasu, Krishan, DeMasi, Ryan, Geier, Jamie, Kwok, Kenneth, Wang, Lisy, Riese, Richard, Wollenhaupt, Jürgen

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry... mā Kremer, Joel M., Bingham, Clifton O., Cappelli, Laura C., Greenberg, Jeffrey D., Madsen, Ann M., Geier, Jamie, Rivas, Jose L., Onofrei, Alina M., Barr, Christine J., Pappas, Dimitrios A., Litman, Heather J., Dandreo, Kimberly J., Shapiro, Andrea B., Connell, Carol A., Kavanaugh, Arthur

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa